Latest News and Press Releases
Want to stay updated on the latest news?
-
NEW YORK, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, today announced its participation in the 25th Annual ICR...
-
Q3 2022 Net Sales of $78.9 millionQ3 2022 Gross margin of 62.4% and adjusted gross margin of 71.9%Q3 2022 Net loss of $16.8 millionQ3 2022 Adjusted EBITDA of $15.3 million, or 19.4% of net...
-
NEW YORK, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, today announced that it will hold a conference call to...
-
NEW YORK, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast” or “the Company”), a global multi-brand beauty and wellness platform, today announced that Philippe Gautier...
-
NEW YORK, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, today announced its participation in the Raymond James...
-
- 1H 2022 Total Net Sales of $138.2 million, increasing 24.6% from 1H 2021- 1H 2022 Gross margin of 73.8%, up 294 bps from 1H 2021- 1H 2022 Pro Forma Adjusted EBITDA margin of 23.5% versus 22.8%...
-
NEW YORK, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, today announced that it will hold a conference call to...
-
Obagi Skincare and Milk Makeup became part of the Waldencast portfolio, and the combined company will begin trading today on the Nasdaq under the ticker symbol “WALD”Waldencast’s vision is to build a...
-
The combined company, Waldencast plc, is expected to begin trading on Nasdaq under the ticker symbol “WALD” starting on July 28, 2022Waldencast will be led by Founder and CEO Michel Brousset and...
-
The business combination with Obagi Skincare and Milk Makeup is expected to close on or around July 27, 2022Strong support from shareholders with approximately 98% approvalThe post-closing combined...